Stock events for Carlyle Secured Lending, Inc (CGBD)
Over the past six months, Carlyle Secured Lending, Inc.'s stock price has declined by 29.26%. The announcement of its third-quarter 2025 financial results, which missed EPS and revenue forecasts, significantly impacted the stock, leading to a price decline and analyst downgrades. Several firms lowered price targets and issued neutral or strong sell ratings in November 2025.
Demand Seasonality affecting Carlyle Secured Lending, Inc’s stock price
Information regarding demand seasonality for Carlyle Secured Lending, Inc.'s products and services is not available in the provided search results.
Overview of Carlyle Secured Lending, Inc’s business
Carlyle Secured Lending, Inc. (CGBD) is an externally managed specialty finance company operating as a business development company (BDC). It provides flexible financing solutions, specializing in direct investments in various forms of debt and equity, focusing on middle-market companies with EBITDA between $25 million and $100 million, often backed by private equity sponsors. The company's sector is Financials, and its industry is Asset Management, targeting a diverse range of industries.
CGBD’s Geographic footprint
Carlyle Secured Lending, Inc. primarily focuses its investments on middle-market companies located in the United States. Additionally, the fund seeks to invest across other regions, including Luxembourg, the Cayman Islands, Cyprus, and the United Kingdom.
CGBD Corporate Image Assessment
Carlyle Secured Lending, Inc.'s brand reputation has been influenced by its financial performance and subsequent analyst reactions in the past year. The third-quarter 2025 earnings miss negatively impacted its reputation, contributing to a stock price decline and analyst downgrades. Despite these challenges, the company maintains a consensus "Hold" rating from analysts, with an average price target of $14.33.
Ownership
Carlyle Secured Lending, Inc. has a significant institutional ownership base, with 167 institutional owners and shareholders holding a total of 28,733,202 shares. Major institutional owners include Creative Planning, Morgan Stanley, and Van Eck Associates Corp. Creative Planning holds 4,631,450 shares as of September 30, 2025. Sjukfoersaekringsaktiebolag Afa is the largest individual shareholder, owning 749,519 shares, representing 1.03% of the company.
Ask Our Expert AI Analyst
Price Chart
$12.98